ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA
K-Number: K200676 · 2020-07-08
Device Summary
Frequently Asked Questions
What is the ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA is a medical device that received FDA 510(k) clearance on 2020-07-08. The listed applicant is Zirkonzahn Srl. The 510(k) number is K200676.
When did ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA receive FDA 510(k) clearance?
ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA received FDA 510(k) clearance on 2020-07-08, under 510(k) number K200676.
Who is the listed applicant for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
The FDA 510(k) record lists Zirkonzahn Srl as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA?
The FDA product code for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA is EBG.
Other records listing Zirkonzahn Srl as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: EBG)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.